Filtros : "Indexado no EMBASE" "EXPRESSÃO GÊNICA" "Hirata, Rosario Dominguez Crespo" Removido: "Hernandes, Antônio Carlos" Limpar

Filtros



Refine with date range


  • Source: Pharmacogenomics. Unidade: FCF

    Subjects: FARMACOGENÉTICA, EXPRESSÃO GÊNICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      WILLRICH, Maria Alice Vieira e HIRATA, Mario Hiroyuki e HIRATA, Rosario Dominguez Crespo. Statin regulation of CYP3A4 and CYP3A5 expression. Pharmacogenomics, v. 10, n. 6, p. 1017-1024, 2009Tradução . . Disponível em: https://doi.org/10.2217/pgs.09.42. Acesso em: 05 jul. 2024.
    • APA

      Willrich, M. A. V., Hirata, M. H., & Hirata, R. D. C. (2009). Statin regulation of CYP3A4 and CYP3A5 expression. Pharmacogenomics, 10( 6), 1017-1024. doi:10.2217/pgs.09.42
    • NLM

      Willrich MAV, Hirata MH, Hirata RDC. Statin regulation of CYP3A4 and CYP3A5 expression [Internet]. Pharmacogenomics. 2009 ; 10( 6): 1017-1024.[citado 2024 jul. 05 ] Available from: https://doi.org/10.2217/pgs.09.42
    • Vancouver

      Willrich MAV, Hirata MH, Hirata RDC. Statin regulation of CYP3A4 and CYP3A5 expression [Internet]. Pharmacogenomics. 2009 ; 10( 6): 1017-1024.[citado 2024 jul. 05 ] Available from: https://doi.org/10.2217/pgs.09.42
  • Source: Pharmacogenomics. Unidade: FCF

    Subjects: EXPRESSÃO GÊNICA, LIPOPROTEÍNAS LDL

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      GENVIGIR, Fabiana Dalla Vecchia e HIRATA, Mario Hiroyuki e HIRATA, Rosario Dominguez Crespo. ABCA1 expression and statins: inhibitory effect in peripheral blood mononuclear cells. Pharmacogenomics, v. 10, n. 6, p. 997-1005, 2009Tradução . . Disponível em: https://doi.org/10.2217/pgs.09.30. Acesso em: 05 jul. 2024.
    • APA

      Genvigir, F. D. V., Hirata, M. H., & Hirata, R. D. C. (2009). ABCA1 expression and statins: inhibitory effect in peripheral blood mononuclear cells. Pharmacogenomics, 10( 6), 997-1005. doi:10.2217/pgs.09.30
    • NLM

      Genvigir FDV, Hirata MH, Hirata RDC. ABCA1 expression and statins: inhibitory effect in peripheral blood mononuclear cells [Internet]. Pharmacogenomics. 2009 ; 10( 6): 997-1005.[citado 2024 jul. 05 ] Available from: https://doi.org/10.2217/pgs.09.30
    • Vancouver

      Genvigir FDV, Hirata MH, Hirata RDC. ABCA1 expression and statins: inhibitory effect in peripheral blood mononuclear cells [Internet]. Pharmacogenomics. 2009 ; 10( 6): 997-1005.[citado 2024 jul. 05 ] Available from: https://doi.org/10.2217/pgs.09.30
  • Source: European Journal of Pharmaceutical Sciences. Unidades: ICB, FCF

    Subjects: EXPRESSÃO GÊNICA, FARMACOGENÉTICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      RODRIGUES, Alice Cristina et al. Decreased ABCB1 mRNA expression induced by atorvastatin results from enhanced mRNA degradation in HepG2 cells. European Journal of Pharmaceutical Sciences, v. 37, n. 3-4, p. 486-491, 2009Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2009.04.006. Acesso em: 05 jul. 2024.
    • APA

      Rodrigues, A. C., Curi, R., Hirata, M. H., & Hirata, R. D. C. (2009). Decreased ABCB1 mRNA expression induced by atorvastatin results from enhanced mRNA degradation in HepG2 cells. European Journal of Pharmaceutical Sciences, 37( 3-4), 486-491. doi:10.1016/j.ejps.2009.04.006
    • NLM

      Rodrigues AC, Curi R, Hirata MH, Hirata RDC. Decreased ABCB1 mRNA expression induced by atorvastatin results from enhanced mRNA degradation in HepG2 cells [Internet]. European Journal of Pharmaceutical Sciences. 2009 ; 37( 3-4): 486-491.[citado 2024 jul. 05 ] Available from: https://doi.org/10.1016/j.ejps.2009.04.006
    • Vancouver

      Rodrigues AC, Curi R, Hirata MH, Hirata RDC. Decreased ABCB1 mRNA expression induced by atorvastatin results from enhanced mRNA degradation in HepG2 cells [Internet]. European Journal of Pharmaceutical Sciences. 2009 ; 37( 3-4): 486-491.[citado 2024 jul. 05 ] Available from: https://doi.org/10.1016/j.ejps.2009.04.006
  • Source: Clinica Chimica Acta. Unidades: FCF, HU

    Subjects: EXPRESSÃO GÊNICA, FARMACOGENÉTICA

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ARAZI, Simone Sorkin et al. Atorvastatin effects on SREBF1a and SCAP gene expression in mononuclear cells and its relation with lowering-lipids response. Clinica Chimica Acta, v. 393, n. 2, p. 119-124, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.cca.2008.03.031. Acesso em: 05 jul. 2024.
    • APA

      Arazi, S. S., Genvigir, F. D. V., Willrich, M. A. V., Hirata, M. H., Dorea, E. L., Bernik, M. M. S., & Hirata, R. D. C. (2008). Atorvastatin effects on SREBF1a and SCAP gene expression in mononuclear cells and its relation with lowering-lipids response. Clinica Chimica Acta, 393( 2), 119-124. doi:10.1016/j.cca.2008.03.031
    • NLM

      Arazi SS, Genvigir FDV, Willrich MAV, Hirata MH, Dorea EL, Bernik MMS, Hirata RDC. Atorvastatin effects on SREBF1a and SCAP gene expression in mononuclear cells and its relation with lowering-lipids response [Internet]. Clinica Chimica Acta. 2008 ; 393( 2): 119-124.[citado 2024 jul. 05 ] Available from: https://doi.org/10.1016/j.cca.2008.03.031
    • Vancouver

      Arazi SS, Genvigir FDV, Willrich MAV, Hirata MH, Dorea EL, Bernik MMS, Hirata RDC. Atorvastatin effects on SREBF1a and SCAP gene expression in mononuclear cells and its relation with lowering-lipids response [Internet]. Clinica Chimica Acta. 2008 ; 393( 2): 119-124.[citado 2024 jul. 05 ] Available from: https://doi.org/10.1016/j.cca.2008.03.031

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024